These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 9807161
1. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides. Zhao G, Lin H, Zhu S, Sun H, Chen Y. Anticancer Drug Des; 1998 Oct; 13(7):769-77. PubMed ID: 9807161 [Abstract] [Full Text] [Related]
2. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K. Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [Abstract] [Full Text] [Related]
3. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J. J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031 [Abstract] [Full Text] [Related]
4. Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl]+ units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding. Zhao G, Lin H, Zhu S, Sun H, Chen Y. J Inorg Biochem; 1998 Jul 27; 70(3-4):219-26. PubMed ID: 9720307 [Abstract] [Full Text] [Related]
5. Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes. Wheate NJ, Webster LK, Brodie CR, Collins JG. Anticancer Drug Des; 2000 Oct 27; 15(5):313-22. PubMed ID: 11354307 [Abstract] [Full Text] [Related]
6. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH, al-Baker S, Thai G, Khokhar AR. Anticancer Drug Des; 1994 Apr 27; 9(2):139-51. PubMed ID: 8166929 [Abstract] [Full Text] [Related]
7. Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes. Wheate NJ, Cullinane C, Webster LK, Collins JG. Anticancer Drug Des; 2001 Apr 27; 16(2-3):91-8. PubMed ID: 11962517 [Abstract] [Full Text] [Related]
8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR. J Inorg Biochem; 2005 Mar 27; 99(3):795-804. PubMed ID: 15708801 [Abstract] [Full Text] [Related]
9. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y. Biomed Pharmacother; 2005 Jun 27; 59(5):224-9. PubMed ID: 15919175 [Abstract] [Full Text] [Related]
10. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles. Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M. Metallomics; 2013 May 27; 5(5):461-8. PubMed ID: 23608770 [Abstract] [Full Text] [Related]
11. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Hollis LS, Sundquist WI, Burstyn JN, Heiger-Bernays WJ, Bellon SF, Ahmed KJ, Amundsen AR, Stern EW, Lippard SJ. Cancer Res; 1991 Apr 01; 51(7):1866-75. PubMed ID: 2004370 [Abstract] [Full Text] [Related]
12. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity. Starha P, Trávnícek Z, Popa I. J Inorg Biochem; 2010 Jun 01; 104(6):639-47. PubMed ID: 20304500 [Abstract] [Full Text] [Related]
13. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity. Kaluderović GN, Schmidt H, Paschke R, Kalinowski B, Dietrich A, Mueller T, Steinborn D. J Inorg Biochem; 2007 Mar 01; 101(3):543-9. PubMed ID: 17223197 [Abstract] [Full Text] [Related]
14. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base. Roy S, Westmaas JA, Buda F, Reedijk J. J Inorg Biochem; 2009 Sep 01; 103(9):1278-87. PubMed ID: 19656572 [Abstract] [Full Text] [Related]
16. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y, Khokhar AR, al-Baker S, Siddik ZH. Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629 [Abstract] [Full Text] [Related]
17. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines. Brodie CR, Collins JG, Aldrich-Wright JR. Dalton Trans; 2004 Apr 21; (8):1145-52. PubMed ID: 15252653 [Abstract] [Full Text] [Related]
18. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes. Zhang J, Li L, Ji X, Sun J, Wang L, Zhang Y. Eur J Med Chem; 2010 Jun 21; 45(6):2634-7. PubMed ID: 20153562 [Abstract] [Full Text] [Related]
19. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. Farrell N, Kelland LR, Roberts JD, Van Beusichem M. Cancer Res; 1992 Sep 15; 52(18):5065-72. PubMed ID: 1516063 [Abstract] [Full Text] [Related]
20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy. Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C. J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]